Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics
NCT03964649 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7308
Last updated 2021-06-02
Summary
To compare rheumatoid arthritis (RA) patient characteristics, adherence, and costs between patients treated with tofacitinib (IR, XR and combined groups) to patients treated with each of the bDMARDs.
Conditions
- Arthritis, Rheumatoid
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2020-04-06
- Completion
- 2020-04-06
Countries
- United States
Study Locations
More Related Trials
-
Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)
NCT00396812 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers
NCT03868072 ·Status: COMPLETED ·Phase: PHASE1
-
A Time to Cardiovascular Event Analysis Comparing Tocilizumab to Other Biologics in Patients With Rheumatoid Arthritis (RA)
NCT02797769 ·Status: COMPLETED
-
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
NCT01636817 ·Status: TERMINATED ·Phase: PHASE2
-
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
NCT01438892 ·Status: COMPLETED
-
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
NCT04721808 ·Status: COMPLETED
-
Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
NCT02097524 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
NCT01893996 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis
NCT00380744 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
NCT06020144 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
NCT04062695 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
NCT00443651 ·Status: COMPLETED ·Phase: PHASE3
-
Rheumatoid Arthritis Satisfaction Outcome Research
NCT03703817 ·Status: COMPLETED
-
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis
NCT01999192 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
NCT00124449 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)
NCT01481493 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Condition of Rheumatoid Arthritis After Treatment
NCT02157012 ·Status: UNKNOWN ·Phase: PHASE4
-
Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
NCT03100253 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)
NCT00794898 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
NCT05487703 ·Status: COMPLETED
-
A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs
NCT03086343 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
NCT02353780 ·Status: TERMINATED ·Phase: PHASE4
-
Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy
NCT01521884 ·Status: COMPLETED
-
The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
NCT05133297 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2